United States - English - NLM (National Library of Medicine)

stat rx usa llc - propranolol hydrochloride (unii: f8a3652h1v) (propranolol - unii:9y8nxq24vq) - propranolol hydrochloride 10 mg - propranolol hydrochloride is a synthetic beta-adrenergic receptor blocking agent chemically described as (±)-1-(isopropylamino)-3-(1-naphthyloxy)-2- propanol hydrochloride. its structural formula is:      structure image propranolol hydrochloride is a stable, white crystalline solid which is readily soluble in water and ethanol. propranolol hydrochloride is available as 10 mg, 20 mg, 40 mg and 80 mg tablets for oral administration. propranolol hydrochloride tablets usp 10 mg, 20 mg, 40 mg, and 80 mg contain the following inactive ingredients: anhydrous lactose, colloidal silicon dioxide, croscarmellose sodium, d and c yellow no. 10, magnesium stearate, microcrystalline cellulose and stearic acid. propranolol hydrochloride tablets usp 10 mg and 80 mg also contain fd and c yellow no. 6. propranolol hydrochloride tablets usp 20 mg and 40 mg also contain fd and c blue no. 1. propranolol is a nonselective beta-adrenergic receptor blocking agent possessing no other autonomic nervous system activity. it s

United States - English - NLM (National Library of Medicine)

nortec development associates, inc - propranolol hydrochloride (unii: f8a3652h1v) (propranolol - unii:9y8nxq24vq) - propranolol hydrochloride 60 mg - propranolol hydrochloride extended-release capsules are indicated in the management of hypertension. it may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. propranolol hydrochloride extended-release capsules is not indicated in the management of hypertensive emergencies. propranolol hydrochloride extended-release capsules are indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. propranolol hydrochloride extended-release capsules are indicated for the prophylaxis of common migraine headache. the efficacy of propranolol in the treatment of a migraine attack that has started has not been established, and propranolol is not indicated for such use. propranolol hydrochloride extended-release capsules improves nyha functional class in symptomatic patients with hypertrophic subaortic stenosis. propranolol is contraindicated in 1) cardiogenic shock; 2) sinus bradycardia and greater than first-degree block; 3)

United States - English - NLM (National Library of Medicine)

a-s medication solutions - propranolol hydrochloride (unii: f8a3652h1v) (propranolol - unii:9y8nxq24vq) - propranolol hydrochloride 80 mg - propranolol hydrochloride extended-release capsules are indicated in the management of hypertension. it may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. propranolol hydrochloride extended-release capsules are not indicated in the management of hypertensive emergencies. propranolol hydrochloride extended-release capsules are indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. propranolol hydrochloride extended-release capsules are indicated for the prophylaxis of common migraine headache. the efficacy of propranolol in the treatment of a migraine attack that has started has not been established, and propranolol is not indicated for such use. propranolol hydrochloride extended-release capsules improve nyha functional class in symptomatic patients with hypertrophic subaortic stenosis. propranolol is contraindicated in 1) cardiogenic shock; 2) sinus bradycardia and greater than first-degree block; 3)

United States - English - NLM (National Library of Medicine)

carilion materials management - propranolol hydrochloride (unii: f8a3652h1v) (propranolol - unii:9y8nxq24vq) - propranolol hydrochloride 60 mg - propranolol hydrochloride extended-release capsules are indicated in the management of hypertension. it may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. propranolol hydrochloride extended-release capsules are not indicated in the management of hypertensive emergencies. propranolol hydrochloride extended-release capsules are indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. propranolol hydrochloride extended-release capsules are indicated for the prophylaxis of common migraine headache. the efficacy of propranolol in the treatment of a migraine attack that has started has not been established, and propranolol is not indicated for such use. propranolol hydrochloride extended-release capsules improve nyha functional class in symptomatic patients with hypertrophic subaortic stenosis. propranolol is contraindicated in 1) cardiogenic shock; 2) sinus bradycardia and greater than first-degree block; 3)

United States - English - NLM (National Library of Medicine)

unit dose services - propranolol hydrochloride (unii: f8a3652h1v) (propranolol - unii:9y8nxq24vq) - propranolol hydrochloride 60 mg - propranolol hydrochloride extended-release capsules are indicated in the management of hypertension. it may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. propranolol hydrochloride extended-release capsules are not indicated in the management of hypertensive emergencies. propranolol hydrochloride extended-release capsules are indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. propranolol hydrochloride extended-release capsules are indicated for the prophylaxis of common migraine headache. the efficacy of propranolol in the treatment of a migraine attack that has started has not been established, and propranolol is not indicated for such use. propranolol hydrochloride extended-release capsules improve nyha functional class in symptomatic patients with hypertrophic subaortic stenosis. propranolol is contraindicated in 1) cardiogenic shock; 2) sinus bradycardia and greater than first-degree block; 3)

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - propranolol hydrochloride (unii: f8a3652h1v) (propranolol - unii:9y8nxq24vq) - propranolol hydrochloride 60 mg - propranolol hydrochloride extended-release capsules are indicated in the management of hypertension. they may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. propranolol hydrochloride extended-release capsules are not indicated in the management of hypertensive emergencies. propranolol hydrochloride extended-release capsules are indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. propranolol hydrochloride extended-release capsules are indicated for the prophylaxis of common migraine headache. the efficacy of propranolol in the treatment of a migraine attack that has started has not been established, and propranolol is not indicated for such use. propranolol hydrochloride extended-release capsules improve nyha functional class in symptomatic patients with hypertrophic subaortic stenosis. propranolol is contraindicated in 1) cardiogenic shock; 2) sinus bradycardia and greater than first-degree block;

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - propranolol hydrochloride (unii: f8a3652h1v) (propranolol - unii:9y8nxq24vq) - propranolol hydrochloride 60 mg - hypertension propranolol hydrochloride extended-release capsules are indicated in the management of hypertension. it may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. propranolol hydrochloride extended-release capsules is not indicated in the management of hypertensive emergencies. angina pectoris due to coronary atherosclerosis propranolol hydrochloride extended-release capsules are indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. migraine propranolol hydrochloride extended-release capsules are indicated for the prophylaxis of common migraine headache. the efficacy of propranolol in the treatment of a migraine attack that has started has not been established, and propranolol is not indicated for such use. hypertrophic subaortic stenosis propranolol hydrochloride extended-release capsules improves nyha functional class in symptomatic patients with hypertrophic subaortic stenosis. propranolol is

United States - English - NLM (National Library of Medicine)

carilion materials management - propranolol hydrochloride (unii: f8a3652h1v) (propranolol - unii:9y8nxq24vq) - propranolol hydrochloride 20 mg in 5 ml - hypertension propranolol hydrochloride is indicated in the management of hypertension. it may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. propranolol is not indicated in the management of hypertensive emergencies. angina pectoris due to coronary atherosclerosis propranolol hydrochloride is indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. atrial fibrillation propranolol hydrochloride is indicated to control ventricular rate in patients with atrial fibrillation and a rapid ventricular response. myocardial infarction propranolol hydrochloride is indicated to reduce cardiovascular mortality in patients who have survived the acute phase of myocardial infarction and are clinically stable. migraine propranolol hydrochloride is indicated for the prophylaxis of common migraine headache. the efficacy of propranolol in the treatment of a migraine attack that has started has not been established, and pro

United States - English - NLM (National Library of Medicine)

baxter healthcare corporation - propranolol hydrochloride (unii: f8a3652h1v) (propranolol - unii:9y8nxq24vq) - injection - 1 mg in 1 ml - intravenous administration is usually reserved for life-threatening arrhythmias or those occurring under anesthesia. - supraventricular arrhythmiasintravenous propranolol is indicated for the short-term treatment of supraventricular tachycardia, including wolff-parkinson-white syndrome and thyrotoxicosis, to decrease ventricular rate. use in patients with atrial flutter or atrial fibrillation should be reserved for arrythmias unresponsive to standard therapy or when more prolonged control is required. reversion to normal sinus rhythm has occasionally been observed, predominantly in patients with sinus or atrial tachycardia.

Malta - English - Medicines Authority

accord healthcare limited - propranolol hydrochloride - film-coated tablet - propranolol hydrochloride 10 mg - beta blocking agents